Feature|Articles|December 10, 2023
- Pharmaceutical Executive: December 2023
- Volume 43
- Issue 12
Pharmaceutical Executive: December 2023 Issue (PDF)
Click the title above for a link to open the Pharmaceutical Executive December 2023 issue in an interactive PDF format.
Advertisement
Articles in this issue
about 2 years ago
Finding that Sparkabout 2 years ago
Remote Reliance: The Rise of Oncology Home Careabout 2 years ago
It’s Always Important to Remember: Leaders Make Mistakesabout 2 years ago
Will Calendar Change Bring an End to Run of Volatility in Biotech?about 2 years ago
FDA, Industry Face Challenges in the Year Aheadabout 2 years ago
Navigating the Future: Key Market Access Trends to Watch in ’24about 2 years ago
Reflecting on 2023Newsletter
Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
J.P. Morgan 2026: Pfizer’s Pivot from Covid to Pipeline Execution
2
JP Morgan 2026: Bristol Myers Squibb Focuses on the Next Decade
3
Johnson & Johnson Announces Second $2 Billion Manufacturing Facility in North Carolina
4
Pharmaceutical Executive Daily: Johnson & Johnson Continues $55 Billion Manufacturing Investment
5